Nahdi Medical Company (TADAWUL:4164)
107.00
+1.60 (1.52%)
Apr 29, 2026, 3:15 PM AST
Nahdi Medical Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | 830.74 | 820.72 | 892.62 | 887.81 | 812.53 | Upgrade
|
| Depreciation & Amortization | 763.17 | 675.92 | 594.95 | 575.75 | 550.48 | Upgrade
|
| Other Amortization | 31.53 | 27.52 | 23.13 | 20.89 | 21.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.49 | -1.54 | -0.22 | 17.42 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -1.6 | -0.5 | -10.11 | -19.49 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.69 | -0.19 | -4.49 | 3.19 | 5.87 | Upgrade
|
| Other Operating Activities | 31.04 | -18.16 | -46.46 | 120.43 | -23.01 | Upgrade
|
| Change in Accounts Receivable | -128.62 | 37.54 | -38.16 | 6.89 | -47.65 | Upgrade
|
| Change in Inventory | -628.34 | -333.74 | -214.62 | -127.01 | 85.85 | Upgrade
|
| Change in Accounts Payable | 170.05 | 338.32 | 257.14 | 153.17 | 43.74 | Upgrade
|
| Change in Other Net Operating Assets | 61.95 | -53.44 | -147.37 | 19.44 | -95.34 | Upgrade
|
| Operating Cash Flow | 1,134 | 1,491 | 1,316 | 1,668 | 1,334 | Upgrade
|
| Operating Cash Flow Growth | -23.98% | 13.32% | -21.09% | 25.03% | -15.88% | Upgrade
|
| Capital Expenditures | -387.09 | -339.53 | -353.86 | -250.27 | -282.57 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.49 | 1.57 | 0.25 | 0.1 | 7.1 | Upgrade
|
| Sale (Purchase) of Intangibles | -30.53 | -44.97 | -30.65 | -24.97 | -23.89 | Upgrade
|
| Other Investing Activities | 62.8 | 54.92 | 52.7 | - | - | Upgrade
|
| Investing Cash Flow | -354.33 | -328.01 | -331.56 | -275.13 | -299.36 | Upgrade
|
| Long-Term Debt Repaid | -453.96 | -401.96 | -435.67 | -416.96 | -382.07 | Upgrade
|
| Total Debt Repaid | -453.96 | -401.96 | -435.67 | -416.96 | -382.07 | Upgrade
|
| Net Debt Issued (Repaid) | -453.96 | -401.96 | -435.67 | -416.96 | -382.07 | Upgrade
|
| Common Dividends Paid | -728 | -715 | -715 | -300.3 | -1,260 | Upgrade
|
| Financing Cash Flow | -1,182 | -1,117 | -1,151 | -717.26 | -1,642 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.19 | 0.77 | -0.45 | -0.21 | -0.02 | Upgrade
|
| Net Cash Flow | -402.37 | 47.15 | -166.65 | 675.27 | -607.49 | Upgrade
|
| Free Cash Flow | 746.64 | 1,152 | 962.17 | 1,418 | 1,051 | Upgrade
|
| Free Cash Flow Growth | -35.18% | 19.71% | -32.13% | 34.83% | -18.50% | Upgrade
|
| Free Cash Flow Margin | 7.31% | 12.19% | 11.04% | 16.45% | 13.04% | Upgrade
|
| Free Cash Flow Per Share | 5.74 | 8.86 | 7.40 | 10.90 | 8.09 | Upgrade
|
| Cash Interest Paid | 141.86 | 115.87 | 50.46 | 79.38 | 78.88 | Upgrade
|
| Levered Free Cash Flow | 397.98 | 814.89 | 645.7 | 1,040 | 712.08 | Upgrade
|
| Unlevered Free Cash Flow | 452.98 | 860.96 | 677.23 | 1,071 | 761.38 | Upgrade
|
| Change in Working Capital | -524.96 | -11.32 | -143 | 52.49 | -13.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.